FDA’s tablet scoring guidance may see provisions removed that would require testing in patients after an advisory committee said patient behavior is too unpredictable to make the approach reliable.
FDA in a 2011 draft guidance wanted manufacturers to test whether their tablet scoring convention allowed patients taking the medicine...